4E Therapeutics is a neuroscience company that develops therapies for chronic neuropathic pain.
4E Therapeutics has raised $5.5M in total funding. The most recent round was Grant. The last funding was announced in November 2021.
4E Therapeutics's investors include National Institutes of Health.
4E Therapeutics is headquartered in Austin, United States.
4E Therapeutics is a neuroscience company that develops therapies for chronic neuropathic pain.
4E Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"4E Therapeutics — Funding & Investors." VCBacked, November 10, 2021, https://www.vcbacked.co/company/4e-therapeutics. Accessed October 19, 2026.
VCBacked. (2021). 4E Therapeutics — Funding & Investors. Retrieved October 19, 2026, from https://www.vcbacked.co/company/4e-therapeutics
{{cite web |title=4E Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/4e-therapeutics |website=VCBacked |access-date=October 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated